Immune modulatory interventions in people with HIV and cancer: prevention, treatment, and implications for HIV eradication.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1110067

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

People with HIV are at increased risk of many cancers. New therapies that target the immune system may be useful in treating these cancers, and may also target the cells where HIV persists thereby assisting in eradication of HIV. This research program includes three clinical studies in people with HIV and cancer: one to learn more about their immunity; one to prevent, and one to treat certain cancers by modulating the immune system. Each also explores any effect on HIV eradication.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Early Career Fellowships

Funding Amount: $344,644.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Epstein-Barr virus (EBV) | human immunodeficiency virus (HIV) | human papillomavirus (HPV) | immune modulation | lymphoma

Related Links